Yongjun Sui, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 41, Room D702
- Bethesda, MD 20892-1578
- 240-760-6726
- suiy@mail.nih.gov
RESEARCH SUMMARY
Dr. Sui's research focuses on the development of mucosal HIV and SARS-CoV-2 vaccine using non-human primate and rodent models. She is interested in identifying innate and adaptive immune correlates of protection against HIV and SARS-CoV-2 infections, as well as exploring trained innate immunity mediated by myeloid cells.
Areas of Expertise
1) immunology 2) virology 3) myeloid-derived suppressor cells 4) innate immunity 5) adaptive immunity 6) trained innate immunity
Yongjun Sui, Ph.D.
Publications
Biography
Yongjun Sui, Ph.D.
Dr. Sui received her Ph.D. in pathology from Beijing Institute of Basic Medical Sciences in 1998, and completed her postdoctoral training at the University of Kansas Medical Center (2002-2005) and University of Pittsburgh (2005-2008). She joined Vaccine Branch, NCI, as a staff scientist in 2008.